Cryo-Cell International (FRA:ZCY) PEG Ratio: N/A (As of Jul. 12, 2026)


FRA:ZCY Cryo-Cell International Inc FRA:ZCY
63 GF Score
Price €2.86
GF Value €4.50
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cryo-Cell International PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Cryo-Cell International's PE Ratio without NRI is 16.53. Cryo-Cell International's 5-Year EBITDA growth rate is 0.00%. Therefore, Cryo-Cell International's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Cryo-Cell International's PEG Ratio or its related term are showing as below:


During the past 13 years, Cryo-Cell International's highest PEG Ratio was 11.45. The lowest was 4.39. And the median was 7.31.


FRA:ZCY's PEG Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.39
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Cryo-Cell International  (FRA:ZCY) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Cryo-Cell International PEG Ratio Related Terms


Cryo-Cell International PEG Ratio Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International PEG Ratio Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 6.90 0.00 0.00 0.00

Cryo-Cell International Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:ZCY vs CCM, CDIX, EHSI: PEG Ratio Comparison

For the Medical Care Facilities subindustry, Cryo-Cell International's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International PEG Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's PEG Ratio falls into.


FRA:ZCY
63GF Score
Cryo-Cell International Inc FRA:ZCY
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Cryo-Cell International's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=16.531791907514/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Cryo-Cell International (FRA:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €2.86 is trading 36.4% below its estimated GF Value™ of €4.50. GuruFocus considers Cryo-Cell International to be Possible Value Trap.

Key valuation signals for FRA:ZCY:

  • PEG Ratio: N/A
  • GF Value™: €4.50 vs. price of €2.86 (36.4% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the FRA:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cryo-Cell International Business Description

Other Exchanges CCEL:USA
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
63GF Score

Get the complete analysis for FRA:ZCY

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.86
Price
€4.50
GF Value